Navigation Links
SleepRight Nasal Breathe Aid Now Available in CVS Caremark
Date:9/3/2013

Kansas City, Missouri (PRWEB) September 03, 2013

“This is a very exciting time for SleepRight,” said Rick Haxton, National Sales Manager for Splintek. “Our customers are looking for long-term solutions to help them sleep better and we have the answer. Now that SleepRight Nasal Breathe Aids are available at their local CVS pharmacy, they can quickly get the help they need to sleep better at night and wake up rejuvenated.”

Splintek, Inc., the creators of the SleepRight NO-BOIL® Dental Guard, designed the revolutionary SleepRight Nasal Breathe Aid, which offers an innovative solution to reduce snoring and relieve nasal congestion. The SleepRight Nasal Breathe Aid helps open a deviated septum and enhances overall breathing performance by increasing oxygen levels. The SleepRight Nasal Breathe Aid’s flexible design gently expands nasal passages to increase airflow and promote a healthy night’s sleep without using skin-pulling adhesives. Each breathe aid is reusable and lasts up to 15 days.

###

Splintek, Inc. is located in Kansas City, Missouri and has been designing health and comfort products since 1996. Splintek owns and operates the SleepRight product line including SleepRight Nasal Breathe Aid, SleepRight Dental Guard, SleepRight Tongue Cleaner, and SleepRight Side Sleeping Pillow. All products are available in the USA and select pharmacies in Canada. For more information call 888.792.0865 or visit http://www.sleepright.com.

Copyright © 2013 Splintek, Inc. SleepRight® and NO-BOIL® are registered trademarks of Splintek, Inc.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11075509.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study: No link between depression, nasal obstruction
2. Steroid Nasal Sprays Show Small Benefit for Sinusitis: Study
3. An advance toward a flu-fighting nasal spray
4. Swallowing Nasal Sprays, Eye Drops Can Harm Kids, FDA Warns
5. Teva to present new Phase III data for QNASL® Nasal Aerosol at the 2012 ACAAI Meeting
6. Overdose education, bystander nasal naloxone rescue kits associated with decreased opioid overdose death
7. Nasal Polyps Treatment
8. How “Nasal Polyps Treatment Miracle” Helps People Treat Nasal Polyps – V-kool
9. Dr. Philip Miller Now Performing MicroRhinoplasty for Nasal Hump Reduction
10. Pregnant Women Who Use Nasal Decongestants During the First Trimester May Increase Their Babies’ Risks of Birth Defects; Parker Waichman LLP Is Evaluating Legal Claims
11. Orange County Facial Plastic Surgeon Talks about Sport Related Nasal Injuries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... New York, NY (PRWEB) , ... April 28, ... ... Shiel Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast ... indicates recent hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back Surgery and ... revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified Anesthesiologist, with ... revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike traditional back ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The Texas ... in recently to the labor and delivery team at Women’s Hospital at Renaissance in ... who give birth at the hospital and decide to donate. , “Women’s Hospital ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... hERG liability could substantially improve drug safety and minimize the cost of development. ... validating ion channel inhibition using cell lines and for cardiac toxicity using induced ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
Breaking Medicine Technology: